KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ginkgo Bioworks Holdings (DNA) Net Margin (2020 - 2025)

Historic Net Margin for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to 207.93%.

  • Ginkgo Bioworks Holdings' Net Margin fell 1445900.0% to 207.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 188.0%, marking a year-over-year increase of 1107700.0%. This contributed to the annual value of 240.94% for FY2024, which is 1141400.0% up from last year.
  • Ginkgo Bioworks Holdings' Net Margin amounted to 207.93% in Q3 2025, which was down 1445900.0% from 121.56% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Net Margin high stood at 63.34% for Q3 2024, and its period low was 1080.85% during Q4 2021.
  • Moreover, its 5-year median value for Net Margin was 245.25% (2024), whereas its average is 356.92%.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Net Margin plummeted by -9361100bps in 2021, and later soared by 9047500bps in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Net Margin (Quarter) stood at 1080.85% in 2021, then skyrocketed by 84bps to 176.1% in 2022, then crashed by -246bps to 609.1% in 2023, then surged by 60bps to 245.25% in 2024, then increased by 15bps to 207.93% in 2025.
  • Its Net Margin stands at 207.93% for Q3 2025, versus 121.56% for Q2 2025 and 188.25% for Q1 2025.